BBR 3464: Began Phase II trial

Novuspharma S.p.A. (NMerct:NOV), Milan, Italy Product: BBR 3464 Business: Cancer Therapeutic category: Cytotoxic Target: DNA Description: Tri-platinum complex Indication: Treat small cell lung cancer ...